An Alzheimer's drug developed by Swiss company Roche could not be proven in clinical trials to slow the progression of dementia, the pharmaceutical giant said Monday.
In a statement, Roche said the drug, gantenerumab, "did not meet their primary endpoint of slowing clinical decline" in a pair of studies conducted by the company. The identical studies, which were conducted with patients over the course of two years, were held in an effort to prove that gantenerumab could preserve certain functions in early Alzheimer's patients, including problem-solving skills, memory, and judgment.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
France and Indonesia promote a contentious bid for an Israel-Palestine two-state solutionTalking Points Both countries have said a two-state solution is the way to end the Middle East conflict
-
Film reviews: Mission: Impossible—The Final Reckoning, Lilo & Stitch, and Final Destination: BloodlinesFeature Tom Cruise risks life and limb to entertain us, a young girl befriends a destructive alien, and death stalks a family that resets fate's toll.
-
Music reviews: Morgan Wallen and Kali UchisFeature "I'm the Problem" and "Sincerely"
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
The Y chromosome degrades over time. And men's health is paying for itUnder the radar The chromosome loss is linked to cancer and Alzheimer's
-
A bacterial toxin could be contributing to the colorectal cancer rise in young peopleUnder the radar Most exposure occurs in childhood
-
Strep infections are rising in the USUnder the radar The cases have more than doubled in 10 years
-
RFK Jr. visits Texas as 2nd child dies from measlesSpeed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
